The DOI matches its Crossref record; 85 of the 87 references it cites were found in a registry or an index.
Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics
Open accessAbstract
The pathogenic mutation in Friedreich's ataxia (FRDA) is a homozygous guanine-adenine-adenine (GAA) trinucleotide repeat expansion on chromosome 9q13 that causes a transcriptional defect of the frataxin gene. Deficiency of frataxin, a small mitochondrial protein, is responsible for all clinical and morphological manifestations of FRDA. This autosomal recessive disease affects central and peripheral nervous systems, heart, skeleton, and endocrine pancreas. Long expansions lead to early onset, severe clinical illness, and death in young adult life. Patients with short expansions have a later onset and a more benign course. Some are not diagnosed during life. The neurological phenotype reflects lesions in dorsal root ganglia (DRG), sensory peripheral nerves, corticospinal tracts, and dentate nuclei (DN). Most patients succumb to cardiomyopathy, and many become diabetic during the course of their disease. This review seeks to reconcile the diverse clinical features with pathological and molecular data. In the pathogenesis of the lesion in DRG, dorsal spinal roots, and sensory peripheral nerves, developmental defects and atrophy occur in combination. The progressive lesion of the DN lacks a known developmental component. Destruction of the DN, optic atrophy, and degeneration of the corticospinal tracts are intrinsic central nervous system lesions. Fiber loss in dorsal columns and spinocerebellar tracts, and atrophy of the neurons in the dorsal nuclei of Clarke are secondary to the lesion in DRG. The role of frataxin deficiency in the pathogenesis of FRDA is still unclear because the protein has multiple functions in the normal state, including biogenesis of iron-sulfur clusters; iron chaperoning; iron storage; and control of iron-mediated oxidative tissue damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Decreased expression of frataxin also increases the Fenton reaction due to excess free iron (17, 220).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [220]
In the citing paper
“In addition, the hypoxia-induced suppression of Fe-S protein activity can be contrasted with the suppression of Fe-S protein activity found in Friedreich's ataxia, a hereditary neurogenerative disease that results from decreased production/function of the frataxin protein (17, 220).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [220]
In the citing paper
“Histological studies and MRI suggest that in human brains the highest iron accumulation occurs in the dentate nuclei of the cerebellum.166,167”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging
Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,513
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
Dürr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.-L., Brice, A., & Koenig, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351601 · Cited by 1,071
Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
Rötig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., & Rustin, P. (1997) · Nature Genetics · doi:10.1038/ng1097-215 · Cited by 991
Harding, A. E. (1981) · Brain · doi:10.1093/brain/104.3.589 · Cited by 929
Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin
Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M., & Kaplan, J. (1997) · Science · doi:10.1126/science.276.5319.1709 · Cited by 921
Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738
Richardson, D. R., Lane, D. J. R., Becker, E. M., Huang, M. L.-H., Whitnall, M., Rahmanto, Y. S., Sheftel, A. D., & Ponka, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912925107 · Cited by 536
Filla, A., Michele, G. D., Cavalcanti, F., Pianese, L., Monticelli, A., Campanella, G., & Cocozza, S. (1996) · PubMed Central · Cited by 487
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood · doi:10.1182/blood-2006-12-065433 · Cited by 409
Flagged first, then by citations
2 of the 87 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Mott, 1907, Case of Friedreich's disease, with autopsy and systematic microscopical examination of the nervous system, Arch Neurol Psychiat Lond, 3, 180
- Vassilopoulos, 1977, Étude radiologique de la colonne vertébrale cervicale dans certaines maladies dégéneratives neurologiques, J Radiol Électrol Méd Nucl, 58, 183
Cited by
Sorted by citations
Items 101–200 of 452
Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
Shah, S., Dooms, M. M., Amaral‐Garcia, S., & Igoillo‐Esteve, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768023 · Cited by 50
Neurodegenerative disorders: Assessing the impact of natural vs drug‐induced treatment options
Mathur, S., Gawas, C. G., Ahmad, I. Z., Wani, M., & Tabassum, H. (2023) · Aging Medicine · doi:10.1002/agm2.12243 · Cited by 51
Friedreich's ataxia—a rare multisystem disease
Reetz, K., Lischewski, S. A., Dogan, I., Didszun, C., Pishnamaz, M., Konrad, K., Marx-Schütt, K., Farmer, J. M., Lynch, D. R., Corben, L. A., et al. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00175-9 · Cited by 48
Mesenchymal Stem Cells Improve Motor Functions and Decrease Neurodegeneration in Ataxic Mice
Jones, J., Estirado, A., Redondo, C., Pacheco‐Torres, J., Sirerol-Piquer, M. S., García‐Verdugo, J. M., & Martı́nez, S. (2014) · Molecular Therapy · doi:10.1038/mt.2014.143 · Cited by 51
Dentate nuclei T2 relaxometry is a reliable neuroimaging marker in Friedreich's ataxia
da Silva, C. B., Bergo, F. P. G., D’Abreu, A., Cendes, F., Lopes‐Cendes, Í., & França, M. C. (2014) · European Journal of Neurology · doi:10.1111/ene.12448 · Cited by 47
Bon, C., Luffarelli, R., Russo, R., Fortuni, S., Pierattini, B., Santulli, C., Fimiani, C., Persichetti, F., Cotella, D., Mallamaci, A., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz798 · Cited by 48
Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia
Profeta, V., McIntyre, K., Wells, M., Park, C. C., & Lynch, D. R. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2173063 · Cited by 46
Spinal Cord Atrophy Correlates with Disability in Friedreich’s Ataxia
Chevis, C. F., da Silva, C. B., D’Abreu, A., Lopes‐Cendes, Í., Cendes, F., Bergo, F. P. G., & França, M. C. (2012) · The Cerebellum · doi:10.1007/s12311-012-0390-6 · Cited by 46
Milestones in Friedreich ataxia: more than a century and still learning
Abrahão, A., Pedroso, J. L., Braga‐Neto, P., Bor‐Seng‐Shu, E., Aguiar, P. D. C., & Barsottini, O. G. P. (2015) · Neurogenetics · doi:10.1007/s10048-015-0439-z · Cited by 45
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases
Mistretta, M., Farini, A., Torrente, Y., & Villa, C. (2023) · Brain · doi:10.1093/brain/awad014 · Cited by 45
Plasterer, H. L., Deutsch, E. C., Belmonte, M. A., Egan, E., Lynch, D. R., & Rusche, J. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063958 · Cited by 45
Samber, B. D., Meul, E., Laforce, B., Paepe, B. D., Smet, J., Bruyne, M. D., Rycke, R. M. D., Bohic, S., Cloetens, P., Coster, R. V., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190495 · Cited by 42
Akhlaghi, H., Yu, J., Corben, L. A., Georgiou‐Karistianis, N., Bradshaw, J. L., Storey, E., Delatycki, M. B., & Egan, G. F. (2013) · The Cerebellum · doi:10.1007/s12311-013-0525-4 · Cited by 44
Britti, E., Delaspre, F., Feldman, A., Osborne, M. A., Greif, H., Tamarit, J., & Ros, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13365 · Cited by 45
Nrf2, cellular redox regulation, and neurologic implications
Benarroch, E. E. (2017) · Neurology · doi:10.1212/wnl.0000000000003946 · Cited by 43
Newborn screening for lysosomal storage disorders and other neuronopathic conditions
Matern, D., Oglesbee, D., & Tortorelli, S. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1117 · Cited by 41
Epidemiology of inherited cerebellar ataxias and challenges in clinical research
Pilotto, F., & Saxena, S. (2018) · Clinical and Translational Neuroscience · doi:10.1177/2514183x18785258 · Cited by 44
The Janus-Faced Role of Lipid Droplets in Aging: Insights from the Cellular Perspective
Bresgen, N., Kovacs, M., Lahnsteiner, A., Felder, T. K., & Rinnerthaler, M. (2023) · Biomolecules · doi:10.3390/biom13060912 · Cited by 41
Alexovič, M., Uličná, C., Sabó, J., & Davalieva, K. (2023) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202300072 · Cited by 40
Cardiovascular Manifestations of Mitochondrial Disease
Duran, J. M., Martinez, A., & Adler, E. A. (2019) · Biology · doi:10.3390/biology8020034 · Cited by 42
Heart-on-a-chip systems: disease modeling and drug screening applications
Butler, D., & Reyes, D. R. (2024) · Lab on a Chip · doi:10.1039/d3lc00829k · Cited by 42
Mitochondrial pore opening and loss of Ca2+ exchanger NCLX levels occur after frataxin depletion
Purroy, R., Britti, E., Delaspre, F., Tamarit, J., & Ros, J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.12.005 · Cited by 37
Iron in Friedreich Ataxia: A Central Role in the Pathophysiology or an Epiphenomenon?
Alsina, D., Purroy, R., Ros, J., & Tamarit, J. (2018) · Pharmaceuticals · doi:10.3390/ph11030089 · Cited by 38
Unanswered Questions in Friedreich Ataxia
Lynch, D. R., Deutsch, E. C., Wilson, R. B., & Tennekoon, G. I. (2012) · Journal of Child Neurology · doi:10.1177/0883073812453498 · Cited by 39
Lai, J., Nachun, D. C., Petrosyan, L., Throesch, B. T., Campau, E., Gao, F., Baldwin, K. K., Coppola, G., Gottesfeld, J. M., & Soragni, E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006515 · Cited by 37
Virmouni, S. A., Sandi, C., Al‐Mahdawi, S., & Pook, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107416 · Cited by 34
Hayashi, G., Shen, Y., Pedersen, T. L., Newman, J. W. I., Pook, M. A., & Cortopassi, G. A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu407 · Cited by 33
Replication Through Repetitive DNA Elements and Their Role in Human Diseases
Madireddy, A., & Gerhardt, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6955-0_23 · Cited by 34
Salami, C. O., Jackson, K. E., Jose, C. L., Alyass, L., Cisse, G.-I., De, B. P., Stiles, K. M., Chiuchiolo, M. J., Sondhi, D., Crystal, R. G., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.363 · Cited by 33
Doni, D., Cavion, F., Bortolus, M., Baschiera, E., Muccioli, S., Tombesi, G., d’Ettorre, F., Ottaviani, D., Marchesan, E., Leanza, L., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06320-y · Cited by 32
Sanz‐Alcázar, A., Portillo-Carrasquer, M., Delaspre, F., Pazos-Gil, M., Tamarit, J., Ros, J., & Cabiscol, E. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103339 · Cited by 33
Collins, A. R. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.05.002 · Cited by 31
Fe/S protein biogenesis in trypanosomes — A review
Lukeš, J., & Basu, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.08.015 · Cited by 31
The Reciprocal Cerebellar Circuitry in Human Hereditary Ataxia
Koeppen, A. H., Ramirez, R. L., Bjork, S. T., Bauer, P. O., & Feustel, P. J. (2013) · The Cerebellum · doi:10.1007/s12311-013-0456-0 · Cited by 31
Self-citationCerebrospinal Fluid Biomarkers in Spinocerebellar Ataxia: A Pilot Study
Brouillette, A. M., Öz, G., & Gomez, C. M. (2015) · Disease Markers · doi:10.1155/2015/413098 · Cited by 33
Hannan, A. J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5434-2_1 · Cited by 34
Cytokine therapy‐mediated neuroprotection in a Friedreich's ataxia mouse model
Kemp, K. C., Cerminara, N. L., Hares, K. M., Redondo, J., Cook, A. J., Haynes, H. R., Burton, B. R., Pook, M. A., Apps, R., Scolding, N. J., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24846 · Cited by 31
Friedreich ataxia: metal dysmetabolism in dorsal root ganglia
Koeppen, A. H., Kuntzsch, E. C., Bjork, S. T., Ramirez, R. L., Mazurkiewicz, J. E., & Feustel, P. J. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-26 · Cited by 30
Self-citationBonnechère, B., Jansen, B., Haack, I., Omelina, L., Feipel, V., Jan, S. V. S., & Pandolfo, M. (2018) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-018-0430-7 · Cited by 32
Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement
Rosa, P. L., Petrillo, S., Bertini, E., & Piemonte, F. (2020) · Biomolecules · doi:10.3390/biom10050702 · Cited by 30
Koeppen, A. H., Ramirez, R. L., Becker, A. B., Feustel, P. J., & Mazurkiewicz, J. E. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000160 · Cited by 30
Self-citationSeco-Cervera, M., Rodríguez, D. G., Ibáñez-Cabellos, J. S., Peiró-Chova, L., González‐Cabo, P., García-López, E., Vilchez, J. J., Sanz‐Gallego, I., Pallardó, F. V., & García‐Giménez, J. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-04996-9 · Cited by 33
Disease-Specific iPS Cell Models in Neuroscience
Peitz, M., Jungverdorben, J., & Brüstle, O. (2013) · Current Molecular Medicine · doi:10.2174/1566524011313050014 · Cited by 29
Dysphagia in Friedreich Ataxia
Keage, M., Delatycki, M. B., Gupta, I., Corben, L. A., & Vogel, A. P. (2017) · Dysphagia · doi:10.1007/s00455-017-9804-4 · Cited by 29
Clinical and genetic aspects of defects in the mitochondrial iron–sulfur cluster synthesis pathway
Vanlander, A. V., & Coster, R. V. (2018) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-018-1550-z · Cited by 29
Recessive cerebellar and afferent ataxias — clinical challenges and future directions
Beaudin, M., Manto, M. U., Schmahmann, J. D., Pandolfo, M., & Dupré, N. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00634-9 · Cited by 30
Li, H., Gakh, O., Smith, D. Y., Ranatunga, W. K., & Isaya, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435263 · Cited by 29
Dey, R., Kemp, K. C., Gray, E., Rice, C. M., Scolding, N. J., & Wilkins, A. (2012) · The Cerebellum · doi:10.1007/s12311-012-0406-2 · Cited by 28
Nachbauer, W., Boesch, S., Schneider, R., Eigentler, A., Wanschitz, J., Poewe, W. H., & Schocke, M. F. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069229 · Cited by 30
Blair, I. A., Farmer, J. M., Hersch, S. M., Larkindale, J., Lynch, D. R., Napierala, J. S., Напиерала, М., Payne, R. M., & Subramony, S. H. (2019) · Future Science OA · doi:10.2144/fsoa-2019-0026 · Cited by 29
Chiang, S., Huang, M. L. H., Park, K. C., & Richardson, D. R. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.019 · Cited by 27
Seminotti, B., Grings, M., Glänzel, N. M., Vockley, J. E., & Leipnitz, G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115433 · Cited by 27
Kruger, P. C., Yang, K. X., Parsons, P. J., Becker, A. B., Feustel, P. J., & Koeppen, A. H. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.04.024 · Cited by 27
Self-citationKrahe, J., Binkofski, F., Schulz, J. B., Reetz, K., & Romanzetti, S. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.019 · Cited by 27
Buesch, K., & Zhang, R. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2112870 · Cited by 26
Longitudinal Strain in Friedreich Ataxia: A Potential Marker for Early Left Ventricular Dysfunction
Sutton, M. S. J., Ky, B., Regner, S. R., Schadt, K. A., Plappert, T. J., He, J., D'Souza, B. A., & Lynch, D. R. (2013) · Echocardiography · doi:10.1111/echo.12287 · Cited by 26
Dysphagia and swallowing-related quality of life in Friedreich ataxia
Vogel, A. P., Brown, S., Folker, J. E., Corben, L. A., & Delatycki, M. B. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7208-4 · Cited by 26
Neuroanatomical Correlates of Depression in Friedreich’s Ataxia: a Voxel-Based Morphometry Study
da Silva, C. B., Yasuda, C. L., D’Abreu, A., Cendes, F., Lopes‐Cendes, Í., & França, M. C. (2012) · The Cerebellum · doi:10.1007/s12311-012-0424-0 · Cited by 26
Pandolfo, M. (2012) · Journal of Child Neurology · doi:10.1177/0883073812448534 · Cited by 26
Purroy, R., Medina‐Carbonero, M., Ros, J., & Tamarit, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101520 · Cited by 26
Yiannakas, M. C., Kakar, P., Hoy, L., Miller, D. H., & Wheeler‐Kingshott, C. A. M. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105544 · Cited by 26
Friedreich Ataxia: Executive Control Is Related to Disease Onset and GAA Repeat Length
Nachbauer, W., Bodner, T., Boesch, S., Karner, E., Eigentler, A., Neier, L., Benke, T., & Delazer, M. (2013) · The Cerebellum · doi:10.1007/s12311-013-0513-8 · Cited by 27
Advances in Reprogramming-Based Study of Neurologic Disorders
Nityanandam, A., & Baldwin, K. K. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0044 · Cited by 25
Sommerville, R. B., Vincenti, M. G., Winborn, K., Casey, A., Stitziel, N. O., Connolly, A. M., & Mann, D. L. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.06.005 · Cited by 25
Neuro-Ophthalmological Findings in Friedreich’s Ataxia
Rojas, P., de Hoz, R., Cadena, M., Salobrar‐García, E., Fernández‐Albarral, J. A., López‐Cuenca, I., Elvira‐Hurtado, L., Urcelay-Segura, J. L., Salazar, J. J., Ramirez, J. M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080708 · Cited by 25
MutLα Heterodimers Modify the Molecular Phenotype of Friedreich Ataxia
Ezzatizadeh, V., Sandi, C., Sandi, M., Anjomani‐Virmouni, S., Al‐Mahdawi, S., & Pook, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100523 · Cited by 24
Söderberg, C. A. G., Rajan, S. S., Shkumatov, A. V., Gakh, O., Schaefer, S., Ahlgren, E.-C., Svergun, D. I., Isaya, G., & Al‐Karadaghi, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442285 · Cited by 25
Peripheral nerve ultrasound in Friedreich ataxia
Mulroy, E., Pelosi, L., Leadbetter, R., Joshi, P., Rodrigues, M. J., Mossman, S., Kilfoyle, D., & Roxburgh, R. H. (2017) · Muscle & Nerve · doi:10.1002/mus.26012 · Cited by 25
Télot, L., Rousseau, E., Lesuisse, E., Garcia, C., Morlet, B., Léger, T., Camadro, J., & Serre, V. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.010 · Cited by 25
Burke, D. J., & Halmagyi, G. M. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.01.023 · Cited by 24
Cardiovascular Research in Friedreich Ataxia
Payne, R. M. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.04.005 · Cited by 25
Xie, Y., & Zhang, R. X. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1989-9 · Cited by 24
Khonsari, H., Schneider, M., Al-Mahdawi, S., Chianea, Y. G., Themis, M., Parris, C., & Pook, M. (2016) · Gene Therapy · doi:10.1038/gt.2016.61 · Cited by 23
Britti, E., Delaspre, F., Sanz‐Alcázar, A., Medina‐Carbonero, M., Llovera, M., Purroy, R., Mincheva-Tasheva, S., Tamarit, J., & Ros, J. (2020) · Biochemical Journal · doi:10.1042/bcj20200331 · Cited by 24
Biochemistry of cardiomyopathy in the mitochondrial disease Friedreich's ataxia
Lane, D. J. R., Huang, M., Ting, S., Sivagurunathan, S., & Richardson, D. R. (2013) · Biochemical Journal · doi:10.1042/bj20130079 · Cited by 24
Hereditary Ataxia: A Focus on Heme Metabolism and Fe-S Cluster Biogenesis
Chiabrando, D., Bertino, F., & Tolosano, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113760 · Cited by 23
Novel aberrant genetic and epigenetic events in Friedreich׳s ataxia
Quesada, M. P., Jones, J., Rodríguez‐Lozano, F. J., Moraleda, J. M., & Martı́nez, S. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.013 · Cited by 23
Marcotulli, C., Fortuni, S., Arcuri, G., Tomassini, B., Leonardi, L., Pierelli, F., Testi, R., & Casali, C. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2427-3 · Cited by 23
Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice
Kemp, K. C., Hares, K. M., Redondo, J., Cook, A. J., Haynes, H. R., Burton, B. R., Pook, M. A., Rice, C. M., Scolding, N. J., & Wilkins, A. (2018) · Annals of Neurology · doi:10.1002/ana.25207 · Cited by 22
Mueller, A., Paterson, E., McIntosh, A., Præstgaard, J., Bylo, M., Hoefling, H., Wells, M., Lynch, D. R., Rummey, C., Krishnan, M. L., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51438 · Cited by 22
Sanz‐Alcázar, A., Britti, E., Delaspre, F., Medina‐Carbonero, M., Pazos-Gil, M., Tamarit, J., Ros, J., & Cabiscol, E. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05064-4 · Cited by 21
Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp ( CTI ‐1601) in Friedreich's ataxia
Clayton, R. G., Galas, T., Scherer, N., Farmer, J. M., Ruiz, N., Hamdani, M., Schecter, D., & Bettoun, D. J. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51971 · Cited by 22
Emerging antioxidant therapies in Friedreich’s ataxia
Edzeamey, F. J., Ramchunder, Z., Pourzand, C., & Virmouni, S. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1359618 · Cited by 23
Iron Pathophysiology in Friedreich’s Ataxia
Li, K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_7 · Cited by 22
Hayashi, G., & Cortopassi, G. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153574 · Cited by 21
Chang, J. C., Ryan, M. R., Stark, M. C., Liu, S., Purushothaman, P., Bolan, F., Johnson, C. A., Champe, M., Meng, H., Lawlor, M. W., et al. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101193 · Cited by 20
White Matter Changes in Patients with Friedreich Ataxia after Treatment with Erythropoietin
Egger, K. E., von Hohenberg, C. C., Schocke, M. F. H., Guttmann, C. R. G., Wassermann, D., Wigand, M. C. C., Nachbauer, W., Kremser, C., Sturm, B., Scheiber‐Mojdehkar, B., et al. (2013) · Journal of Neuroimaging · doi:10.1111/jon.12050 · Cited by 22
Mitochondrial diseases: expanding the diagnosis in the era of genetic testing
Saneto, R. P. (2020) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2020.40 · Cited by 21
Jones, J., Estirado, A., Redondo, C., & Martı́nez, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062807 · Cited by 21
Chapdelaine, P., Gérard, C., Sanchez, N., Cherif, K., Rousseau, J., Ouellet, D. L., Jauvin, D., & Tremblay, J. P. (2016) · Gene Therapy · doi:10.1038/gt.2016.36 · Cited by 21
Mollá, B., Riveiro, F., Bolinches-Amorós, A., Muñoz-Lasso, D. C., Palau, F., & González‐Cabo, P. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024273 · Cited by 19
Sensory neuronopathies: new genes, new antibodies and new concepts
Fargeot, G., & Echaniz‐Laguna, A. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325536 · Cited by 20
The Cerebellum Looks Normal in Friedreich Ataxia
Mascalchi, M. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3480 · Cited by 19
Longitudinal Study of Cognitive Functioning in Friedreich’s Ataxia
Hernández-Torres, A., Montón, F., Medler, S. H., de Nóbrega, É., & Nieto, A. (2020) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617720000958 · Cited by 18
Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?
Pilotto, F., Bondio, A. D., & Puccio, H. M. (2024) · Cells · doi:10.3390/cells13040319 · Cited by 25
Measuring peripheral nerve involvement in Friedreich’s ataxia
Creigh, P. D., Mountain, J., Sowden, J. E., Eichinger, K. J., Ravina, B. M., Larkindale, J., & Herrmann, D. N. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50865 · Cited by 18
Doni, D., Rigoni, G., Palumbo, E., Baschiera, E., Peruzzo, R., Rosa, E. D., Caicci, F., Passerini, L., Bettio, D., Russo, A., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202000524rr · Cited by 19
Cherif, K., Gérard, C., Rousseau, J., Ouellet, D. L., Chapdelaine, P., & Tremblay, J. P. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.009 · Cited by 19
Characterizing cardiac phenotype in Friedreich's ataxia: The CARFA study
Legrand, L., Weinsaft, J. W., Pousset, F., Ewenczyk, C., Charles, P., Hatem, S. N., Heinzmann, A., Biet, M., Dürr, A., & Redheuil, A. B. (2021) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2021.10.010 · Cited by 17
Muñoz‐Zuluaga, C., Gertz, M. L., Yost-Bido, M., Greco, A., Gorman, N., Chen, A., Kooner, V., Rosenberg, J. B., De, B. P., Kaminsky, S. M., et al. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.020 · Cited by 17
Metadata
- Authors
- Koeppen, A. H.
- Affiliations
- Albany Stratton VA Medical Center Albany (US)
- Corresponding author
- Koeppen, Arnulf H.
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 303
- Issue
- 1-2
- Pages
- 1-12
- ISSN
- 0022-510X (ISSN-L)
- PMC
- PMC3062632
- OpenAlex
- W1985093325
- Cited by
- 447
- References
- 87
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 36 · 2023: 34 · 2022: 18 · 2021: 22 · 2020: 25 · 2019: 27 · 2018: 21 · 2017: 27 · 2016: 30 · 2015: 30 · 2014: 38 · 2013: 52 · 2012: 28
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Friedreich's Ataxia Research Alliance
- National Ataxia Foundation
- National Institutes of Health
- Neurochemical Research, Inc.
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Friedreich's ataxia, GAA trinucleotide repeat expansion, frataxin deficiency, frataxin gene, iron chaperone, dorsal root ganglia, sensory neuropathy, dentate nucleus, corticospinal tract degeneration, cardiomyopathy, diabetes mellitus, autosomal recessive disorder, pathogenesis, clinical phenotype
- MeSH terms
- Frataxin, Adolescent, Adult, Aged, Animals, Child, Child, Preschool, Disease Models, Animal, Female, Friedreich Ataxia, Humans, Infant, Male, Middle Aged, Spinal Cord, Age of Onset, Iron-Binding Proteins, History, 19th Century, History, 20th Century, History, 21st Century, Mice, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review